Tuesday, June 7, 2016

Valeant cuts forecasts again

Quarterly earnings at the embattled drug maker swung from a profit to a loss. Valeant's stock has fallen 90 percent since August. Fred Katayama reports.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)